Back to search

Article

The ongoing oleoylethanolamide story: therapeutic implications in the control of obesity and its comorbidities

2026-03-10

Abstract excerpt

The global burden of obesity continues to rise, demanding effective pharmacological strategies for individuals in whom prevention alone is insufficient. Recent incretin-based and multi-agonist therapies have delivered unprecedented weight loss, demonstrating that the simultaneous modulation of multiple metabolic pathways can optimize body weight control and improve obesity-related comorbidities. Yet the biological...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
04bba49d-84db-5ede-85d8-31a2e19e4b4c
DOI
10.22541/au.177313174.48225874/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The ongoing oleoylethanolamide story: therapeutic implications in the control of obesity and its comorbiditiesDOI 10.22541/au.177313174.48225874/v1
Select a neighboring publication to make it the new centre.